Alzheimer's and Dementia Research Webinars

Join the Alzheimer’s Association and ISTAART for a series of webinars that share the latest advances in Alzheimer's and dementia research, as well as strategies for career development.

More information on the types of webinars offered can be found here


Found 269
Sort By

Nutrition, Metabolism and Dementia PIA: Understanding the mechanistic link between type-2 diabetes and Alzheimer's disease

June 1, 2022
This webinar discusses novel approaches in preclinical models to understand why individuals with type-2-diabetes have a 2-4 fold increase risk for developing AD and identify new therapeutic mechanisms that target brain metabolism.
PIA - Nutrition,Metabolism and Dementia

Down Syndrome and Alzheimer's Disease & Technology and Dementia PIAs: Technology and dementia in Down syndrome: maximizing collaborations between PIAs

May 31, 2022
We feature four scientists with expertise in Down syndrome, technology and dementia. Webinar focuses on how technological strategies can promote meaningful assessment and timely diagnosis of Alzheimer's disease in individuals with Downs syndrome.
PIA - Down Syndrome and Alzheimer's Disease PIA - Technology and Dementia

ISTAART Journal Club: Meet the Author

May 25, 2022
Mareike Ludwig leads a conversation with Anne S Berry and then Tia Lamore leads conversation with Winston Thomas Chu and David E. Vaillancourt
ISTAART Journal Club: Meet the Author PIA - Neuromodulatory Subcortical Systems

Technology and Dementia & Health Policy PIA's - Technology and Policy: A Panel Discussion on How Policy Impacts Our Work and How Our Work Can Impact Policy

May 24, 2022
This webinar helps technology researchers, policymakers and industry stakeholders describe how their work can impact policy. Panelists present their experiences at the intersection of research and policy and engage in a Q&A.
PIA - Health Policy PIA - Technology and Dementia

Clinical Trials Advancement and Methods & Diversity and Disparities PIAs: Increasing sustained diversity in Alzheimer's disease and related dementia clinical trials.

May 23, 2022
There is a need for AD clinical trials to improve recruitment, enrollment, and retention of diverse populations to ensure potential treatments are safe, effective, accessible, and equitable. Globalization of AD clinical trials is also discussed.
PIA - Diversity and Disparities PIA - Clinical Trials Advancement and Methods

Neuroimaging PIA: Getting started with connectomics analysis

May 12, 2022
This webinar is a primer on how to setup, generate, review and interpret structural and functional connectivity analyses. Speakers go over best practices and what pitfalls to watch out for with their work.
PIA - Neuroimaging

Vascular Cognitive Disorders PIA: New advances in biomedical sciences transferable to VCID research?

May 6, 2022
We discuss recent advances in three-photon microscopy and single-molecule imaging as tools to deeper brain regions and intra-cellular dynamics. We focus on the feasibility and transferability of technologies for VCID research.
PIA - Vascular Cognitive Disorders

Subjective Cognitive Disorders PIA: Subjective complaints in the setting of AD clinical trials

May 5, 2022
We examine subjective complaints in AD clinical trials with an emphasis on the role in trial design, recruitment, and outcome measurement in preclinical AD trials that enroll cognitively unimpaired participants who are biomarker eligible.
PIA - Subjective Cognitive Decline

PIA to Elevate Early Career Researchers - Early Career Dementia Researchers: Drivers of Discovery

May 4, 2022
How are dementia early career researchers (ECRs) doing? We present results from the 2021 PEERs/UCL global survey of dementia ECRs, covering careers and more.
PIA - PIA to Elevate Early Career Researchers

Diversity and Disparities PIA & Society for Behavioral and Cognitive Neurology (SBCN): Racial Disparities in Disorders of Cognition

May 3, 2022
We raise awareness for the need of diverse practitioners and how to recruit patients representing underserved populations. We explore how symptoms and treatments vary across populations and how to ensure equitable, accessible care for all.
PIA - Diversity and Disparities